<DOC>
	<DOCNO>NCT00824954</DOCNO>
	<brief_summary>Purpose : evaluate efficacy ECP child refractory acute GVHD This study address patient persistent GVHD steroid and/or monoclonal antibody therapy</brief_summary>
	<brief_title>Extracorporeal Photopheresis Children Young Adults With Refractory Acute Graft Versus Host Disease</brief_title>
	<detailed_description>One arm . Six session two week . Classification complete response ( resolution sign GVHD ) , partial response ( improvement least one grade ) absence response ( Glucksberg criterion ) . Tapering depend patient condition week 2 10 . Final evaluation week 10 . Steroid therapy taper discretion investigator .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>0 30 year Acute GVHD refractory steroid ( disease progression 2 day absence response 4 day ) and/or second line therapy ( absence response 8 day ) patient consent and/or parent consent le 10 kg BW clinical biological state preclude apheresis previous GVHD therapy antilymphocyte serum ( excepted condition regimen )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>0 30 year</keyword>
	<keyword>Refractory Acute GVHD</keyword>
</DOC>